Nomenclature
CAS number: 15421-84-8
N,N-Diethyl-5-methyl-[1,2,4]triazolo[1,5-
a]pyrimidin-7-amine; 7-diethylamino-5-methyl-
s-triazolo[1,5-
a]pyrimidine; trapymin; AR-12008; Avantrin (Inverni); Rocornal (Rodleben).
C
10H
15N
5; mol wt 205.26.
C 58.51%, H 7.37%, N 34.12%.
Description and references
First triazolopyrimidine registered as a drug.
Prepn: E. Tenor et al., DD 55956 (1967), C.A. 67, 90830f (1967); E. Tenor, R. Ludwig, Pharmazie 26, 534 (1971). Physical and chemical properties: S.
Pfeifer et al., ibid. 539. Pharmacology and
toxicology: H. Fuller et al., ibid. 554. Metabolic
studies: S. Pfeifer et al., ibid. 549; ibid. 27, 752 (1972); I. Bornschein et al., ibid. 33, 51 (1978). Mechanism of action: K. Satoh et al., Arzneim.-Forsch. 30, 1264 (1980).
Antiarrhythmic activities in rabbits: M. Sakanashi et al., ibid. 33, 215 (1983).
Clinical hemodynamic effects: M. Di Donato et al., ibid. 35, 1295 (1985). GC determn
in biological fluids: A. Marzo et al., ibid. 37, 947 (1987).
Properties
White to yellowish, odorless and bitter crystalline
powder, mp 98-99.4° (Pfeifer); 102-104° from heptane (Tenor). Eutectic
temp of mixture with azobenzene: 48°. Very sol in water, 1N sulfuric acid, 10% ammonium hydroxide; easily sol in methanol, isopropanol, n-butanol, chloroform and benzene; sol in ether. Practically
insol in hexane, heptane. pKs = 2.79. uv max (methanol):
222, 270, 307 nm (log ε 4.28, 3.83, 4.28). Very stable except under
extremely alk conditions. LD50 in mice,
rats (mg/kg): 115, 76 i.v.; 380, 235 orally; 155, 100 i.p.; 132, 100 s.c. (Fuller).Derivative
Hydrochloride.
C
10H
15N
5.HCl; mol wt 241.72.
C 49.69%, H 6.67%, N 28.97%, Cl 14.67%.
Properties
mp 212°.Therapeutic Category
Vasodilator (coronary).
Keywords
Vasodilator (Coronary)